Related Experiment Video

Updated: Jan 3, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.3K

Kaposi sarcoma in patients on tumour necrosis factor alpha inhibitors: a case-noncase study

M Sáinz-Gil1,2, P Rodríguez-Jiménez3, M E Cárdaba4

  • 1Facultad de Medicina, Centro de Estudios sobre la Seguridad de los Medicamentos (CESME), Universidad de Valladolid, Valladolid, Spain.

Journal of the European Academy of Dermatology and Venereology : JEADV
|November 17, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K

Related Experiment Videos

Last Updated: Jan 3, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.3K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K

Articles linked to this work by shared authors, journal, and citation graph.

Link Between Non-Invasive Intrapartum Interventions and Cardiotocography Patterns, Amniotic Fluid Color, and Immediate Neonatal Outcomes.

Healthcare (Basel, Switzerland)·2026

Improving Risk Stratification for SLNB in Elderly Patients With Melanoma: The SENTINOLD Nomogram.

International journal of dermatology·2026

Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).

Pharmacology research & perspectives·2025

Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma.

Cancers·2024

Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database.

British journal of clinical pharmacology·2024

Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology.

European journal of hospital pharmacy : science and practice·2023

Adverse pregnancy outcomes in women with atopic dermatitis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Disease progression in hidradenitis suppurativa: A multidimensional framework.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Management of chronic urticaria: Current status and future prospect.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Spatial immune biomarkers in triple-negative breast cancer: emerging evidence, technology trade-offs, and barriers to clinical translation.

Frontiers in immunology·2026

Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting.

Cancer biology & medicine·2026

Muscle-invasive urothelial carcinoma of the bladder in a direct inguinal hernia.

BMJ case reports·2026

TREM2⁺ tumor-associated macrophages in cancer: context-dependent biology, biomarkers and precision immunotherapy.

Critical reviews in oncology/hematology·2026

STING Expression in Pituitary Neuroendocrine Tumour Immune Microenvironments.

Endocrine-related cancer·2026

Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes.

The Journal of clinical investigation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us